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Human studies, critical for developing new diagnostics and therapeutics, are limited by 
ethical and logistical issues, and preclinical animal studies are often poor predictors of 
human responses. Standard human cell cultures can address some of these concerns 
but the absence of the normal tissue microenvironment can alter cellular responses. 
Three-dimensional cultures that position cells on synthetic matrices, or organoid or organ-
on-a-chip cultures, in which different cell spontaneously organize contacts with other cells 
and natural matrix only partly overcome this limitation. Here, we review how human organ 
cultures (HOCs) can more faithfully preserve in  vivo tissue architecture and can better 
represent disease-associated changes. We will specifically describe how HOCs can be 
combined with both traditional and more modern morphological techniques to reveal 
how anatomic location can alter cellular responses at a molecular level and permit com-
parisons among different cells and different cell types within the same tissue. Examples 
are provided involving use of HOCs to study inflammation, cancer, and stem cell biology.
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iNTRODUCTiON
Preclinical animal studies have had only limited success in predicting human physiology, pathology, 
and therapeutic responses. Traditional human cell cultures, which are often used to account for 
species differences are also limited in their representation of in vivo responses due to lack of an 
appropriate microenvironmental context of the responding cell types. Newer culture approaches, 
such as three-dimensional (3D) cultures, organoids, or organs-on-a-chip have attempted to better 
replicate the tissue microenvironment, but have been only partly successful. In this review, we will 
illustrate how human organ cultures (HOCs) offer a simple approach that may better address these 
issues. To do so, we have chosen illustrative examples from the literature from the past 30 years that 
have been used to gain insights into inflammatory process and diseases, cancer, and stem cell biology. 
More recent examples have illustrated how newer morphological approaches, such as in situ proxim ity 
ligation assay, can be applied to HOCs to reveal greater details in specific biological responses.
MeTHODOLOGY OF HOC
The Method Described Here Reflects Our Approach for 
Optimizing HOC
Tissue for HOC (Figure 1) is transported to the laboratory as quickly as possible to minimize dete-
rioration, ideally within minutes of collection. “Time zero” samples are processed concomitant with 
FiGURe 1 | Schematic diagram of human organ culture (HOC) setup. Tissue is immersed in a sterile universal container with tissue culture medium (M199 
supplemented with 5% heat-inactivated fetal calf serum, 100 U/ml penicillin/streptomycin, 2.2 mM l-glutamine) (A). Tissue is rinsed in sterile phosphate-buffered 
saline (PBS) to remove excess blood (B). Tissue is dissected under a dissecting microscope using two sterilized carbon steel razor blades single-edged stuck 
together creating a gap of <1 mm3 (C). Tissue fragments are immersed in sterile 96-well plate containing 200 µl medium and sterile culture insert, treated as 
indicated, or left untreated and maintained in a 37°C incubator (95% air, 5% CO2) for the indicated time periods (usually less than 24 h) (D). Upon harvest, HOCs  
are either immersed in fixative (paraformaldehyde for light microscopy or gluteradehyde for electron microscopy) or in RNA later or snap-frozen in isopentane-cooled 
in liquid nitrogen for molecular biological/biochemical analysis (e). IHC, immunohistochemistry; IF, immunofluorescence; PLA, in situ proximity ligation assay; TUNEL, 
terminal transferase-mediated d-UTP nick end labeling; TEM, transmission eIectron microscopy; IGEM, immunogold EM.
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the onset of organ culture to establish morphological features 
prior to culture and treatments. Excess blood can be removed 
by immersing tissue in sterile phosphate-buffered saline prior 
to transfer into a sterile petri-dish for dissection into <1 mm3 
fragments using two sterilized carbon steel single-edged razor 
blades (T585; Agar Scientific, UK) stuck together under a dis-
secting microscope (to aid in sample selection and orientation). 
However, other groups have documented use of various tools 
for dissecting tissue for OCs such as a Leica VT1200 S vibrating 
blade microtome with Vibrocheck (1), a biopsy punch (2, 3), 
motor-driven coring tool (4), and a Krumdieck tissue slicer (1, 
5). For each tissue, multiple samples can be collected from dif-
ferent regions. For example, in the kidney samples can be taken 
from the medulla through to the cortex. The dissected fragments 
are immediately immersed in 200 µl of tissue culture medium 
(e.g., M199 containing 5% heat-inactivated fetal calf serum, 
100  U/ml penicillin/streptomycin, 2.2  mM l-glutamine) in 
a sterile 96-well plate containing culture inserts, treated as 
indicated, or left untreated and maintained in a 37°C incubator 
(95% air, 5% CO2) for the desired time periods (usually less than 
24 h). Culture conditions may need to be altered depending upon 
the tissue source, but we have successfully used this formulation 
for kidney, heart, and skin HOCs. Replicate samples for each 
treatment and time point are used to assess reproducibility. In 
our experience, we observe a rapid deterioration of morphology 
in culture of kidney samples incubated for longer than 18  h. 
During incubation, organ cultures remain metabolically and 
physiologically active and respond to external stimuli. Upon 
harvest, HOCs can be immersed in fixative (e.g., paraformalde-
hyde for light microscopy or gluteradehyde for electron micros-
copy), or in RNA later, or snap-frozen in isopentane-cooled in 
liquid nitrogen for molecular biological/biochemical analysis. 
Organ cultures of human kidney, heart, skin, and tumors can 
all be conducted using similar technique (6–10).
MeTHODS THAT CAN Be APPLieD ON 
HOCs
Advances in molecular and biochemical techniques have 
increased the power of HOCs (Table 1). The ability to perform 
replicate cultures that can be sampled throughout a treatment 
TABLe 1 | Methodologies that can be used to analyze human organ cultures and key findings.
Type of explants Methodology Key findings Reference
Human skin IHC E-selectin is a marker for activation of endothelial cells (ECs) (23)
Normal human skin  
and skin with psoriasis
Autoradiography, IHC,  
biochemical methods
[125] EGF binding was increased in psoriatic epidermis compared  
to normal skin, and increased EGF receptor phosphorylation
(26)
Newborn foreskins TEM, IGEM, IHC Microvascular endothelium of skin can undergo activation in response  
to exogenous/endogenous cytokines, with most pronounced changes  
seen at sites involved in leukocyte trafficking
(22)
Neonatal skin IHC, WB Cytokines known to be present in psoriatic skin induce EGF/TGF-α receptor  
and TGF-α expression in neonatal skin
(27)
New born human foreskin IHC Demonstrated mediators involved in the induction and regulation of ICAM-1 (15)
Human skin IHC, IEM Cytokine responses of microvasculature is altered in psoriasis (31)
Human umbilical artery 
and vein
Gene delivery using adenovirus 
vectors in cultures
Demonstrated that adenovirus vectors are not of value for gene delivery to  
uninjured vascular endothelium in situ, and are unlikely to be suitable for  
genetic manipulation for vascular endothelium in organs for transplantation
(41)
Human tonsillar and 
appendix
WB Demonstrated protein expression of mediators involved in upregulation  
of endothelial VAP-1
(13)
Human saphenous vein 
(de-endothelialized)
Histochemical stains (van Giessen, 
Miller’s elastic), H&E, IHC
ANG II increased DNA synthesis to a greater extent than in isolated cell cultures  
of saphenous vein smooth muscle cells, mediated in part by angiotensin receptor 1
(49)
Human skin WB, RT-qPCR, geletainolytic 
zymogram
Demonstrated multiple cytokines can regulate expression of MMP-9 transcript  
and protein and in human skin
(18)
Human saphenous vein MTT, Hoechst 333258, TUNEL, 
H&E, Verhoeff’s Van Gieson
Early molecular events occurring in the arterialization of human vein grafts are  
controlled by hemodynamic conditions
(67)
Normal cervical tissue  
and CIN II/III lesions
IHC rhTRAIL and MG132, a proteosomal inhibitor, synergize to induce apoptosis,  
especially in CIN II/III lesions
(2)
Human umbilical tissue RT-qPCR, IHC, FACS, WB Arterial and venous ECs in cultured human umbilical tissue activate different  
transcription factors and upregulate different adhesion molecules in response to TNF
(24)
First trimester human 
placental villous and 
extravillous tissue
siRNA, WB Silencing of GCM1 upregulated by forskolin treatment resulted in cell  
proliferation and promoted de novo syncitiotrophoblast formation in  
syncytially denuded floating villous explants
(46)
Human skin adhered  
to acellular dermis
RT-qPCR, IHC, histometric 
analyses, WB
HRG-activated HER3 contributes to the outgrowth process of epidermis (30)
Healthy skin and skin  
from patients with ESRD
IHC, WB, ELISA Production of MMP1, TIMP-1 but not type I procollagen is increased in  
skin of ESRD-treated with omniscan (gadodiamide). Indicated omniscan  
alters enzyme/inhibitory system responsible for collagen turnover in the skin  
and directly stimulates hyaluronan production
(36)
Normal human kidney, 
and renal transplants 
undergoing ACR and ATN
IHC, ISH, TUNEL TNFRs are differentially regulated and activate different signaling pathways in  
normal, inflamed and ischemic human kidney
(9)
Human tonsil Histology, IHC, and histochemistry Reported preservation of structure and function in normal and neoplastic  
colon tissue
(39)
Human skin IHC, FACS Lentiviral tropism in skin tissue is distinct from tropism to keratinocytes in  
culture, and dependent on three-dimensional architecture of the tissue
(42)
Human neonatal foreskin DNA extraction/Dot blot by  
image density quantification, IHC
Detected UV-induced DNA damage and repair in skin (43)
Normal human kidney  
and RCC explants
IHC Resident cancer stem cells are increased in RCC. Selective ligation of  
TNF receptor 2 can induce stem cell proliferation, increasing susceptibility  
to cell cycle-dependent cytotoxicity
(10)
Human saphenous vein  
and coronary artery
H&E, histochemical stains  
(Alcian blue, Miller’s elastin,  
and Van Gieson)
Quantified cell numbers and neointimal area in vascular cultures (20)
Chemokine multiplex immunoassay, 
IHC, WB, histology, saturation and 
competition analysis, RT-qPCR
CCR-5 mRNA and protein in venous smooth muscle consistent with  
receptor binding, and that CCL4 and CCL5 are vasoconstrictors in the  
human saphenous vein
Human prostate cancer Adenoviral gene delivery, IHC STAT5a/b induces epithelial-to-mesenchymal transition in human  
prostate cancer
(48)
(Continued )
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FiGURe 2 | (A) RCC organ cultures treated with recombinant human TNF for 3 h and subjected to immunogold electron microscopy. Colloidal gold particles 
representing localization of phospho-MLKL (Ser358) (5 nm) and phospho-dyamin-related protein-1 (Drp1) (Ser616) (10 nm) and are detected in mitochondria (m). 
Mag: 105k×. (B) Representative light micrograph of RCC organ cultures treated with recombinant human TNF for 3 h were subjected to in situ hybridization using 
anti-sense probe to RIPK3 conjugated with Digoxigenin (DIG). Intense blue staining using anti-DIG-alkaline phosphatase and BCIP/NBT substrate (blue color) is 
seen in sites of gene expression within the cytoplasm of tumor cells. Original mag: 63×. (C) Representative confocal image of RCC organ cultures treated with 
recombinant human TNF for 3 h and subjected to in situ proximity assay to determine interaction between RIPK3 and phosphorylated-MLKL (Ser358). Numerous 
strong red fluorescent spots are evident within the cytoplasm of malignant TECs (mTECs) indicating close proximity of RIP3/pMLKL (<40 nm). Original mag: 63×. 
TNF, tumor necrosis factor.
Type of explants Methodology Key findings Reference
Normal human kidney and 
renal clear cell carcinoma 
(RCC)
IHC, TUNEL, IGEM, In situ PLA Expression of TNFRs and signaling pathways activated are different  
in RCC compared to normal kidney
(8, 10)
Human colon and 
pulmonary biopsies
siRNA, WB Silencing of Cyclin D1 expression by siRNA delivered by invivofectamine  
or nanoliposomes in colon but not lung organ cultures
(47)
Precision-cut human  
kidney slices
CytoTox-ONE homogeneous 
membrane integrity assay
Measurement of ATP content and LDH leakage indicated viability of cultures (3)
HPLC Measurement of uridine 5 diphospho-glucuronosyl transferase  
indicated cell functionality in cultures
WB, RT-qPCR Determined TGFβ1-induced activation and upregulation of fibrotic  
markers at the RNA and protein level
ESRD, end-stage renal disease; GCM1, glial cell missing-1; H&E, hematoxylin and eosin; IHC, immunohistochemistry; WB, western blot; RT-qPCR, real-time quantitative polymerase 
chain reaction; FACS, fluorescence activated cell sorting; siRNA, small interference ribonucleic acid; ELISA, enzyme-linked immunosorbent assay; HPLC, high performance liquid 
chromatography; TGF-α, transforming growth factor alpha; TGF, transforming growth factor; ATP, adenosine triphosphate; LDH, acetate dehydrogenase; VAP-1, vascular adhesion 
protein-1; rhTRAIL, recombinant human tumor necrosis factor (TNF)-apoptotic inducting ligand; TNFRs, TNF receptors; GCM1, glial cells missing homolog 1; HRG, high heregulin; 
EGF, epidermal growth factor; RCC, renal clear cell carcinoma; ACR, acute cellular rejection; ATN, acute tubular necrosis; NK, normal kidney; ICAM-1, intracellular adhesion molecule; 
TUNEL, terminal transferase-mediated d-UTP nick end labeling; LPS, lipopolysaccharide; ANG II, angiotensin II; CIN, cervical intraepithelial neoplasia; PLA, proximity ligation assay; 
IGEM, immunogold electron microscopy; TEM, transmission electron microscopy; STAT, signal transducer and activator of transcription; CCR-5, C–C chemokine receptor type 5; CCL, 
chemokine (C–C motif) ligand; VSMC, vascular smooth muscle cell; MMP, matrix metalloproteinase; TIMP, tissue inhibitors of metalloproteinase; HER, human epidermal growth factor.
TABLe 1 | Continued
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period and the resolution offered by advances in labeling and 
imaging technologies allows detailed analysis of responses 
of both spatial and temporal to treatment within a tissue at a 
molecular level. Confocal microscopy can resolve molecules 
in the 200  nm ranges, and immunogold electron microscopy 
provides opportunities to resolve the cellular localization and 
phosphorylation status of proteins at a resolution of <10  nm 
(Figure  2A). Localization of gene expression can be studied 
using in  situ hybridization (Figure 2B). New technologies can 
extend the potential of traditional immunolocalization assays 
to study molecular interactions. The in  situ proximity ligation 
assay can be used to detect single molecules at a subcellular level 
and detect protein interactions in response to external stimuli 
(Figure 2C). The application of this technique to HOC provides 
the capability to study dynamic molecular interactions in  situ 
with high spatial resolution.
HOCs PReSeRve CeLLULAR 
ReSPONSeS THAT MAY Be LOST  
iN CeLL CULTUReS
Human organ cultures can be used to study physiological 
responses to mediators that are lost in cell cultures. For example, 
in organ cultures of normal human kidney, TGF-β1 promotes 
fibrogenesis in parallel with increased expression of multiple 
fibrotic markers including heat shock protein 4, fibronectin 
1, type 1A collagen (COL1A1), and α-smooth muscle actin 
(α-SMA), but not vimentin, E-cadherin, and CD31. TGF-β1 
pathway also increases plasminogen activator inhibitor 1, a 
downstream signaling molecule (3). These various responses 
to TGF-β1 differ from those seen in primary cultures or cell 
lines derived from different renal cell types (11, 12). In human 
tonsil organ cultures, pro-inflammatory cytokines, such as TNF, 
5Al-Lamki et al. Human Organ Culture
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IL-1, IL-4, IFN-γ, and lipopolysaccharide (LPS) each induce 
marked upregulation of vascular adhesion protein (VAP)-1, 
a molecule important for leukocyte recruitment across high 
endothelial venules of secondary lymphoid organs (13, 14). 
Cultured endothelial cells (ECs), including ECs cultured from 
human tonsil, fail to express VAP-1 when exposed to these same 
agents. In human skin organ cultures, IFN-γ induces lCAM-1 
expression primarily on ECs and epidermal keratinocytes (KCs) 
whereas IL-6, GM-CSF and macrophage-CSF induce ICAM-1 
expression on both ECs and dermal dendritic cells (DCs) but 
not KCs. IL-1α or IL-β induce ICAM-1 expression on DCs while 
TNF affects primarily ECs and IL-3 does not affect any cell type 
(15). These varied responses to cytokines again differ from those 
of human dermal ECs and KCs in cell culture (16). In the same 
HOC system, the expression of the major histocompatibility 
antigens (MHC) class II (HLA-DR/DQ) is induced by IFN-γ in 
microvascular ECs and epidermal DCs [Langerhans cells (LC)] 
but not on KCs whereas IFN-γ does induce MHC class II mol-
ecules on cultured human KCs (17). Also in skin organ cultures, 
pro-MMP-9 expression is induced by TGFβ, which is increased 
by TNF (18). TNF (but not TGFβ) promotes proteolytic activa-
tion of pro-MMP-9 by conversion of the 92-kDa pro-MMP-9 
to the 82-kDa active enzyme. This TNF-mediated proteolytic 
activation of pro-MMP-9 is undetected in isolated cultures of 
dermal fibroblast or epidermal KCs (19). In HOCs of saphenous 
vein both contractile and proliferative vascular smooth muscle 
cells (VSMCs) express CCR-5, a chemokine receptor implicated 
on atherosclerosis, in response to ligands CCL4 and CCL5 (20). 
In contrast, cultured VSMCs from human saphenous vein do not 
express CCR-5 when similarly stimulated (21).
HOCs CAN ReveAL POSiTiONAL 
eFFeCTS UPON CeLLULAR ReSPONSeS
Endothelial cells play a key role in many different disease pro-
cesses and while they are often considered as a single cell type, 
their phenotype, functions, and responses to stimuli in vivo are 
very sensitive to anatomic position. For example, the superficial 
vascular plexus (SVP) of human skin allows ready distinction 
of arterioles, capillaries, and venules with capillary arcades 
confined to the dermal papillae that nurture the epidermis and 
with paired arterioles and venules running parallel to the epi-
dermal layer but below the epidermal rete. In response to TNF 
or LPS, only ECs lining postcapillary venules (PCV) of the SVP 
will express E-selectin (22), i.e., the same vessel segments typi-
cally associated with inflammatory infiltrates in vivo in elicited 
delayed-type hypersensitivity reactions (23). In the same HOCs, 
ECs lining arterioles and capillaries are responsive to these same 
mediators by increasing their expression of ICAM-1. In other 
words, the anatomic position of the ECs determines how, but 
not whether the ECs respond to specific inflammatory stimuli. 
In contrast, all cultured human dermal ECs will upregulate 
E-selectin and ICAM-1. Similarly, in HOCs of umbilical cords, 
where the paired arteries and single vein are also readily dis-
tinguished, the ECs lining umbilical veins respond to TNF by 
expressing E-selectin, whereas ECs lining umbilical arteries 
will not. In the same HOCs, arterial ECs respond to TNF by 
expressing higher levels of ICAM-1 than do umbilical vein ECs. 
Remarkably, these differences begin to narrow in as little as a 
few hours and are completely erased by 3 days in cell culture, 
at which time both arterial and venous ECs assume a common 
phenotype that differs from both types of ECs in situ and show 
intermediate degrees of both ICAM-1 and E-selectin induction. 
The change in the behavior of arterial ECs upon harvest and 
cell culture has been attributed to loss of shear stress-induced 
modifiers of the TNF response such as Kruppel-like factor 2, 
but the changes in venous EC, which also show loss of shear 
stress-induced factors, albeit from lower starting levels, are in 
the opposite direction of those observed in arterial ECs (24). 
The rapidity of the alterations in cytokine responses upon iso-
lation supports the interpretation that the differences in TNF 
responses are determined by the microenvironmental context 
in which these cells are located, for example on distinct types of 
basement membrane, rather than by stable epigenetic changes. 
Thus, even though cell culture experiments allow the discovery 
and evaluation of cytokine actions on ECs, cultured ECs lose the 
ability to identify responses that vary with the anatomic origin 
of the cell, a feature amenable to study in HOCs. This loss of 
positional responses in human umbilical veins ECs occurs in 
both 2D and 3D cultures. Remarkably, when Bcl-2 transduced 
human umbilical vein ECs, which are indistinguishable from 
control ECs in 2D culture, are placed into 3D cultures and then 
implanted into immunodeficient mice, they form vessels that 
become perfused and acquire arteriolar, venous, and capillary 
morphologies and gain characteristic segmental responses to 
TNF. To date, organoid cultures that form vessels do not allow 
distinctions among vascular segment types.
HOCs CAN Be USeD TO STUDY STeM 
CeLLS
Human organ cultures can be used to study stem cells within their 
niche. For example, in human cardiac tissue affected by ischemic 
heart disease, resident stem cells, identified as small round 
cells that express CD133 but not CD45, express TNF receptor 
2 (TNFR2) and respond to TNF, in a manner dependent upon 
TNFR2 signaling, by entering cell cycle and expressing charac-
teristic markers of mature cardiomyocytes (7). This potentially 
beneficial response of resident cardiac stem cells to TNF may 
have contributed to the adverse effects of anti-TNF therapies in 
human heart failure. HOCs can also allow comparisons of normal 
and tumor stem cells. Renal organ cultures also contain CD133+ 
resident stem cells, which are more abundant in renal clear cell 
carcinoma (RCC) than in normal kidney. In organ cultures of 
RCC and corresponding non-tumor kidney, TNFR2 engagement 
on CD133+ resident stem cells results in increased TNFR2 expres-
sion and promotes cell cycle entry. Importantly, while TNFR2 
effects are not directly harmful to these stem cells, TNFR2-
driven cell cycle entry increases their sensitivity to cell cycle- 
dependent cytotoxic agents (10). These findings have indicated 
that priming tumor stem cells with a TNFR2 agonist may enhance 
the efficiency of chemotherapy for RCC.
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HOCs CAN ReveAL ALTeReD 
ReSPONSeS AND SiGNALiNG PATHwAYS 
iN DiSeASe
inflammatory Diseases
Human organ cultures of skin from patients have provided 
insights into inflammatory disease pathogenesis. Psoriasis 
vulgaris, which displays hyperproliferation of the epidermal 
KCs, is characterized by overexpression and altered distribu-
tion of the EGF/TGF-α receptor, and of TGF-α itself. In normal 
stratified epithelium, the expression of EGF/TGF-α receptor is 
restricted to the basal and intermediate suprabasal KCs (25). 
However, in active psoriatic lesions, expression of EGF/TGF-α 
receptor is seen in the basal and subcorneal layers of stratified 
epithelium (26). TNF and IFN-γ induce EGF/TGF-α receptor 
expression in basal and suprabasal cells in non-stimulated 
explants in KCs in all layers of the epidermis (27). In contrast 
primary cultures of KCs cannot reproduce these position-
related differences (28, 29). Moreover, treatment of skin HOCs 
with EGFR family members increases keratinocyte prolifera-
tion and neoepidermal thickness (30), mimicking psoriasis-like 
changes. ECs of the SVP in skin HOCs generated from psoriatic 
lesions, sites uninvolved by lesions and perilesional skin from 
the same patient provide an additional example of disease-
related altered responses. The ECs in cultures from uninvolved 
sites and perilesional sites do not show expression of E-selectin 
and VCAM-1, whereas in lesional skin, both molecules are 
expressed on ECs of PCV and, significantly, on the ECs lining 
the remodeled (venularized) capillaries in the dermal papillae 
of the SVP. In skin HOCs from uninvolved sites, similar to skin 
HOCs from healthy donors, TNF induces E-selectin on the 
ECs lining PCVs whereas VCAM-1 is not inducible on these 
same cells, even when TNF is combined with IL-4. However, 
in perilesional skin biopsies from psoriatic patients, which is 
devoid of leukocytes, VCAM-1 can be induced on SVP venular 
ECs by the combination of TNF and IL-4, suggesting a change 
in the responsiveness of these ECs related to a disease process 
that precedes overt plaque spreading (31).
Human organ cultures of normal and pathologic colon have 
demonstrated that different bacterial species adhere in a peculiar 
manner to the proximal and distal colonic compartments of the 
mucosal surface (32). A consistent adhesion of Streptococcus 
thermophillus and Bifidobacterium infantis but not Lactobacillus 
acidophilus, with B. infantis adhering to the proximal compared 
to the distal segments. In contrast to cell cultures of human 
intestinal epithelial cell lines, which show differential adhesion 
profiles of bacterial strains (33), with L. acidophilus as the most 
adherent strain in intestinal mucosa (34). Findings from cell 
cultures for bacterial adherence capacity to epithelial cells are 
difficult to extend to the situation in the human gastrointestinal 
tract and it is unknown if intestinal organoids will be more useful 
in this regard.
Systemic Diseases
Human organ cultures of skin have been used to study how 
systemic processes may influence cutaneous responses. Magnetic 
resonance imaging gadolinium-based contrast agents (GBCAs) 
appear to be a trigger of nephrogenic systemic fibrosis in a small 
subset of patients with end-stage renal disease (ESRD) (35). 
DaSilva et al. (36) compared responses to GBCAs in human skin 
organ cultures and in isolated dermal fibroblast and KC cultures, 
using skin from individuals with ESRD and from normal individ-
uals. Skin organ cultures treated with GBCA (Omniscan) show 
increased MMP1 production, TIMP-1 and hyaluronan produc-
tion but not collagen type-1. Responses were seen in patients with 
ESRD and controls, but basal levels were higher in patients with 
ESRD. These potentially pathogenic responses were detected in 
KCs in monolayer culture, and although similar responses were 
observed in fibroblasts, there was no difference in responses in 
2D cultured fibroblasts isolated from the skin of normal patients 
as compared to patients with ESRD.
Organ Transplantation
Cytokine effects in human kidney are cell type specific and also 
depend on anatomical location. In normal kidney, ECs of glo-
merular and peritubular capillaries (PTCs) express higher levels 
of TNF receptor 1 (TNFR1) associated with inactive apoptosis 
signal-regulating kinase-1 (ASK1pSer967) and an absence of 
activated ASK1 (ASK1pThr845). Other renal cell types lack both 
TNFR1 and ASK1. TNFR2 is only minimally expressed in any 
cell type in normal kidney. This expression pattern of TNFRs 
differentiates renal cells in situ from cultured renal cells where 
both receptors are typically expressed in the same cell. It also 
differs from the patterns seen in rejecting renal allografts or 
ischemia reperfusion injury where resident renal cells lose 
TNFR1 expression and ECs of PTCs and tubular epithelial cells 
(TECs) express TNFR2 (9). Effects of TNF signaling on differ-
ent renal cell populations can be analyzed in organ cultures. 
Treatment of normal kidney organ cultures with a TNFR1-
selective mutein results in activation of ASK1 and induction 
of cell death in ECs of glomerular and PTC, while a TNFR2-
selective mutein upregulates TNFR2, results in phosphorylation 
of endothelial-epithelial tyrosine kinase (Etk) and initiates cell 
cycle entry in ECs of PTC and in TECs. TNF does not affect the 
expression of either receptor in cultured renal cells. In kidneys 
injured by allograft rejection, despite showing reduced or even 
absent expression of TNFR1, activated ASK1pThr845 is seen in 
both ECs and TECs, and this has been linked to expression 
of an alternative receptor, DR3, that is absent from cultured 
renal cells (9).
Cancer
In RCC organ cultures, a TNFR1-selective mutein promotes cell 
death in malignant TECs (mTECs) selectively expressing ASK1, 
with the majority of the cells dying via necroptosis involve 
the receptor-interacting protein (RIP1)/RIP3/phosphorylated 
mixed lineage kinase domain like (MLKL)/dyamin-related 
protein-1 (Drp1). As an example of how modern morphologi-
cal approaches can be applied in HOCs, physical interactions 
between signaling intermediates have been demonstrated 
using in situ proximity ligation assay. In the same HOC system 
a TNFR2-selective mutein promotes cell cycle via reciprocal 
phosphorylation of Etk and vascular growth factor receptor 2 
7Al-Lamki et al. Human Organ Culture
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(VEGFR2) in mTECs, whereas VEGF activates VEGFR2, but 
not Etk, suggesting Etk–VEGFR2 interactions and cell cycle 
activation in mTECs are specific to TNFR2 signaling. TNFR2 
expression increases with increasing cancer grade providing a 
model to study the effects of regulated expression of the recep-
tor in a pathophysiological setting. These data have important 
therapeutic implications, suggesting that inhibitors of VEGFR 
may be more effective than neutralization of VEGF because 
TNF-TNFR2 signaling may provide an alternative and possibly 
more effective VEGF-independent means to activate this mito-
genic receptor (8). Once again, this behavior revealed in organ 
culture cannot be replicated in isolated cell cultures of human 
TEC lines (DPK-KTEC-H and HK2). In the context of brain 
tumors, tumor cells’ susceptibility to TNF-related apoptosis-
inducing ligand (TRAIL) and lack of activity in healthy cells 
led to speculation that TRAIL could be used in cancer therapy 
(37). However, in organ cultures of adult human brain slices, 
trimerized TRAIL increased death in a large number of cells in 
the cortex and white matter as compared to untreated cultures 
with damaged cells identified as neurons, oligodendrocytes, 
astrocytes, and microglial cells (38). Another study examined 
the role of calcium (Ca2+)/calcium-sensing receptor (CaSR) in 
regulation of growth and differentiation in normal and malignant 
colon HOCs (39). Lower third of the crypt in normal cultures 
showed proliferation while extracellular CaSR expression was 
present in the surface epithelium and upper third. E-cadherin 
and β-catenin were expressed at the cell surface between 
adjacent cells. In malignant tissue, in contrast to normal tissue, 
proliferation was detected throughout the epithelium with dif-
fuse or absence of CaSR. Expression of β-catenin was detected 
throughout the cytoplasm and nucleus. Expression of E-cadherin 
was seen at the cell surface (as in the normal tissue) with diffuse 
expression throughout the cytoplasm in some areas. In contrast 
to colon carcinoma cells where extracellular Ca2+ did not induce 
E-cadherin or result in a shift in β-catenin from the cytoplasm 
to the cell membrane, Ca2+ treatment resulted in growth reduc-
tion in mock-transfected cells and in a Ca2+-responsive variant 
line derived from the same parental colon carcinoma cells. This 
was accompanied by increased production of E-cadherin and 
a shift in β-catenin distribution from the cytoplasm to the cell 
membrane (40).
HOCs CAN Be USeD TO STUDY 
THeRAPeUTiCS
Human organ cultures of blood vessels have been used to deter-
mine gene delivery efficiency of a replication-defective adenovirus 
5 vector carrying the [beta]-galactosidase reporter gene to vascu-
lar ECs (41). In contrast to cultured human primary vascular ECs, 
which were efficiently infected (>90%) at adenovirus concentra-
tions of >1010pfu/ml, non-dividing vascular endothelium in situ 
was very poorly transduced, casting doubt on the utility of this 
class of vector in vivo. Similarly, skin HOCs have been used to 
characterize the factors that determine lentiviral vector tropism 
and findings compared to monolayer cultures of KCs (42). While 
early monolayer cultures of progenitor KCs expressing keratin 
15+/63+ are lentiviral vector-permissive, they are resistant to 
transduction in their native niche in the skin. Alternatively, 
transiently amplified keratin 14+ KCs are permissive to lentiviral 
transduction, in cell culture and in the skin, after separation of 
epidermis from dermis layer. Keratin 14+ KCs in the human skin 
hair follicles are resistant to lentiviral transduction even after 
partial digestion of the extracellular matrix (ECM) collagen. Thus 
lentiviral vector tropism to KCs in organ culture is distinct from 
tropism to KCs in cell culture.
In HOCs of skin, topical imiquimod, a pharmacological agent 
that facilitate the development of skin cancer through accu-
mulation of genetic lesions failed to enhance DNA repair after 
UV-exposure (43). In contrast to imiquimod-treated epidermal 
bone marrow-derived cells (BMDCs) (43), attributing these 
differences to the KCs in the epidermal layer lacking TLR7/8 
while BMDCs such as LCs express TLR7/8 (44). A differential 
response to imiquimod has also been observed in stimulated 
KCs monolayers (HaCaT cells, immortalized human KCs and 
primary KCs), which failed to show DNA repair in contrast to 
stimulated KG-1, a monocytic cell line (43). These data sug-
gested that LCs activated by imiquimod might potentially influ-
ence neighboring KCs and thus provide an indirect protection 
against UV damage. HOCs of normal squamous cervical tissue 
and CIN II/III lesions have been used to evaluate the effect of 
a potential anticancer drug rhTRAIL (recombinant human 
TRAIL) alone or in combination with a proteasome inhibitor 
MG132 (2). MG132 induced increased sensitivity in CIN II/III 
cultures as compared to normal cultures, which was enhanced 
by treatment with rhTRAIL. In contrast, immortalized and 
transformed cells lines, which serve as a model for cervical 
carcinogenesis, show variable sensitivity to proteosomal inhibi-
tion to rhTRAIL (45). Among the human cervical cancer cell 
lines HeLa were moderately, CaSki was highly and SiHa was 
insensitive to rhTRAIL-induced apoptosis. However, MG132 
resulted in a marked rhTRAIL-induced cell death in HeLa and 
SiHa in a time- and caspase-dependent manner. HOCs can 
also be treated with various pharmacological inhibitors, short 
interfering RNAs (siRNA), or anti-sense oligonucleotides to 
gain insights into molecular function of cells in situ (46–48). In 
human colon and lung organ cultures, stimulus LPS-activated 
endothelium (EC-LPS), induced a marked expression of Cyclin 
D1. Treatment of cultures with siRNA for Cyclin D1, in pres-
ence or absence of EC-LPS, resulted in approximately 46% 
reduction of Cyclin D1 compared to the basal condition, and 
by approximately 65% compared to colon samples treated with 
EC-LPS after 24 h (47). In organ cultures of prostate cancer, in 
which Stat5a/b-mediates epithelial-to-mesenchymal transition 
(EMT) (epithelial-mesenchyme transition), disruption of Jak2/
Stat5a/b signaling by specific inhibitors resulted in a significant 
decrease in active nuclear Stat5a/b but not Stat3, increase levels 
in E-cadherin and simultaneously a decrease in levels of Twist1 
indicating that active Stat5a/b signaling promotes expression of 
EMT markers (48). In studies of first trimester human placental 
explants denuded of villous cytotrophoblasts, siRNA and anti-
sense oligonucleotides silencing of GCM1 (glial cell missing-1 
transcription factor), which mediates syncytialization and pro-
liferation, resulted in a strong inhibition of syncytiotrophoblast 
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reformation, and increased proliferation of cytotrophoblast 
(46). In organ cultures of human de-endothelialized saphen-
ous veins, an effector peptide of the renin-angiotensin system 
Angiotensin II (Ang II), induced a strong increase in DNA 
synthesis over 7  days, associated with increased proliferation 
and hyperplasia in media of vein. Treatment of cultures with 
Tyrphostin-23; a selective inhibitor of tyrosine kinases sig-
nificantly abolished the effects of Ang II while PD123319, a 
selective AT2 receptor antagonist had no significant effect on 
the Ang II response (49). In contrast Ang II failed to stimulate 
DNA synthesis in cultured SMCs from human saphenous 
vein or from human coronary arteries (50, 51).
COMPARiSON OF HOCs TO eMeRGiNG 
CeLL CULTURe MeTHODS
3D Cultures
A wide range of 3D in vitro models is emerging to better mimic 
the human physiology and, at the same time, to reduce animal 
experiments (52). 3D cultures use different types of porous 
scaffolds, derived from naturally and engineered substrates (53). 
Gene expression profiles of cancer cells often differ in cells grown 
in 3D as compared to 2D cultures. In particular genes involved in 
angiogenesis, proliferation, invasion, migration, and chemosen-
sitivity (54). 3D cultures have been used to determine the effects 
of cytokines (55) and cells seeded into a 3D cardiac ECM scaffold 
have shown increased calcium signaling and kinetics promot-
ing stem cell maturation (56). However, in contrast to HOCs, 
ECM scaffolds used in 3D cultures fail to emulate the natural 
biochemical and physical properties of the ECM recognized as 
independent factors that influence cell activity (57). Furthermore, 
basement membrane-derived scaffolds may contain undesired 
components like viruses and growth factors. Indeed, other 
matrices permit cell attachment but not easy detachment of cell 
making assay development difficult. Even with the generation of 
3D biological scaffolds via organ de-cellularization (58), current 
systems fail to offer complex in vivo tissue vasculature for supply 
of nutrients and oxygenation as well as removal of waste mate-
rial necessary for promoting attachment, differentiation, and 
proliferation of cells. Moreover, clonal variation across various 
strains of cell lines and 3D culture techniques used in different 
laboratories may also influence data. Unlike HOC, cell lines used 
in 3D cultures lose many of their native in vivo characteristics 
once removed from the primary tissue. Moreover, most research 
that uses in  vitro models ignores the origins of cell lines and 
histological characteristics because of the unavailability of these 
data. For example, SKOV3, an epithelial ovarian cancer cell line 
widely used in 3D in  vitro model for studying ovarian cancer 
bears striking histological resemblance to a clear cell ovarian 
cancer, which is the least common histological subtype of inva-
sive disease (59).
3D Bioprinting
This system incorporates biology and tissue engineering to 
develop biological substrates that restore, improve, and main-
tain tissue function. The three most common 3D-bioprinting 
mechanisms include inkjet (a non-contact printing technology 
that reproduces digital patterns onto a substrate using tiny ink 
drops), laser (uses laser energy to vaporize the solution of bio-
logical samples and eject the remaining substances), or extrusion 
bioprinting (uses temperature-controlled polymerized materials 
for scaffold fabrication) (60). All these methods combine solid 
free-form fabrication and precise placement of cells and other 
biological factors to the desired 2D and 3D positions. This system 
offers additional biocompatibility and capacity for uniform cell 
incorporation. It begins with intrinsic organization and offers a 
template to guide reconstruction of cells and thus create a bio-
mimmicked tissue with high throughput and cell manipulation. 
Use of personalized tissue substitutes promotes and enhances 
regeneration in areas of defected tissue (61). This system has 
shown promise in gene and drug delivery with precise placement 
during tissue construction. However, compared to HOCs, the 
limitations of this system include difficulties in managing single 
cells, over-drying leading to the failure of biological systems, 
and cell damage and altered phenotype caused by the printing 
process. Bioprinting requires fine-tuning of matrices for optimal 
conditions of simulation and deposition of cells and scaffolds. 
Also the current strategies still cannot fabricate new tissue that 
is indistinguishable from native tissue in  vivo with respect to 
the zonal organization, ECM composition, and mechanical 
properties. Introduction of structures in vivo to facilitate organ 
regeneration have shown that infused cells may fail to maintain 
their formation in the recipient (61). Thus, the precise delivery 
of cells and biological factors to the desired 3D cultures is still 
far from being resolved.
Organoids
This system stands at the forefront of 3D approaches as it more 
accurately recapitulates in  vivo characteristics of the original 
individual’s tissue because the ECM and cell–cell interactions 
are intrinsic to the culture. Organoids have been successfully 
generated from human healthy and diseased tissue and pluri-
potent stem cells (62). Organoids from primary tissue sustain 
basement membrane extracts that are hallmarks of the original 
tissue in terms of architecture, cell type composition, and self-
renewal properties. Patient-specific organoids have allowed 
functional genomic studies that can be related to the diagnosis 
of a patient and, with future development, will contribute to the 
generation of personalized therapies. However, in comparison 
to HOCs, organoids lack histological diversity and sequential 
differentiation as occurs in adult human tissue. They also lack 
surrounding tissue that is important for the interplay of cell–cell 
and cell–ECM cross talk, requires structural support to promote 
continuity and proper orientation of cell growth and can be quite 
heterogeneous from tissue to tissue and fail to generate tissue 
of origin. For example generation of cerebral organoids that 
have used embryonic bodies (EBs) kept in suspension leads to 
uniform neural ectoderm formation along the outer surface of 
EBs, whereas inner non-neural mesendodermal tissues do not 
develop, and the neurons do not display a six-layered architecture 
such as that seen in vivo (63). Cultures are also prone to acquir-
ing independent secondary alterations and can quickly grow 
beyond the limits of stationary diffusion of oxygen and nutrients. 
TABLe 2 | Summary of the strength and weakness of the human organ culture (HOC) with emerging cell cultures.
Strength weakness
2D cell cultures Simple model, easy to manipulate, low cost A static system of cell growth that does not reflect the situation in vivo. 
Lacks cell–cell and cell–extracellular matrix (ECM) interactions
Uniform rich oxygenation. Nutrients are provided to all cells, and 
waste products are secreted directly into the media
Growth on plastic flasks/plates affect polarity, morphology and  
migratory properties of cells
Easy environment to control, allowing manipulation of cells Extended passages may alter the phenotype and histological 
characteristics of cells
Can be used as a platform for drug testing Fails to mimic a physiological microenvironment. Inability to depict  
traits exhibited using in vivo systems
Can be conveniently observed and analyzed by imaging 
techniques
Three-dimensional (3D)  
cell cultures
Recreates cell–cell and cell–ECM contact that mimic the in vivo 
natural environment promoting spatial organization and high 
density culturing
More expensive and time consuming than 2D cultures
Provides a simple but efficient tool for investigating cellular 
responses non-invasively and in real time under physiologically 
relevant conditions
Lacks natural stromal architecture and some molecules important  
for promoting attachment, differentiation and proliferation of cells
Cells can survive prolonged incubation ECM scaffolds do not recapitulate the complexity of the in vivo matrix  
and substrate elasticity can effect cell morphology and function
Great promise for drug discovery, provides predictive response of 
drug activation and safety in organ-specific cells
ECM scaffolds may contain biological pathogens and show batch- 
to-batch variability in composition
Show better response to exogenous stimuli and withstands more 
stress when countered by cytotoxic agents
ECM scaffolds may effect mechanical strain and flow shear stress  
dynamic models
Induces changes more relevant to disease models Vascular networks lack segmental structure
Cell morphology/function may alter in culture, either as a result of 
passaging before introduction into the scaffold or direct contact with  
the scaffold
3D Bioprinting Provides material with optimal rheological properties that can 
restore, maintain, and improve tissue formation
Very expensive and technically difficult. Requires fine-tuning for optimal 
conditions. Different imprinting methods have different limitations
Offers additional biocompatibility and capacity for targeted  
cell incorporation at specific sites
Printing process may cause cell damage and alter cell phenotype.  
Infused cells may not be incorporated
Potential for high throughput when optimal conditions have been 
established
Materials can suffer batch-to-batch variation and difficulties with  
scale-up
Organoids Retains tissue identity and closely recapitulate 3D structural 
organization
Can require scaffolds/polymers to provide structural organization and 
promote continuity and proper orientation of cell growth
Amenable to high throughput drug screening; patient-derived 
organoids allow 5personalized therapy design
Growth of cells requires careful formulation of media/supplements
(Continued )
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Thus, although promising in their application, 3D cultures and 
organoids have not as yet accurately reflect the characteristics 
of primary human cells in vivo.
Organ-in-a-Chip
This emerging 3D cell-culture model better mimics the micro-
structure, dynamic mechanical properties, and biochemical 
functionalities of living organs. It integrates microfluidic 
devices created with microfabrication techniques (photoli-
thography, replica molding, and microcontact printing) using 
living cells cultured within 3D devices to study human physiol-
ogy in an organ-specific context, and to develop specialized 
in  vitro disease models (64). Structures with defined shapes 
and positions are created by microfabrication techniques on 
the micrometer scale to position cells and tissues, control cell 
shape, and function, and create highly structured 3D culture 
microenvironments. The development of a multi-analytic 
optical sensing module for dynamic measurements of pH 
and dissolved oxygen levels in the culture medium has been 
recently reported (65). Small amounts of fluids are manipu-
lated in microfabricated hollow channels to generate and 
precisely tune dynamic fluid flows and spatiotemporal gradi-
ents, as well as deliver nutrients and other chemical cues to 
cells in a controlled manner. However, HOCs retain several 
advantages over organ-on-a-chip. The latter still remains an 
artificial model relying on microfabricated scaffolds to mimic 
ECM, and thus failing to recapitulate in  vivo tissue. These 
systems lack multi-organ interactions that are critical to some 
aspects of drug metabolism and toxicity. Interrelationship and 
cross talk between multiple cell types and the dynamics for 
modulating physiological processes are currently too complex 
to be recapitulated in such a system. Table 2 summarizes the 
strengths and weakness of all emerging cell cultures as com-
pared to HOCs.
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Strength weakness
Can be readily expanded and frozen to create a master  
“cell-bank” for subsequent use
Cell growth can be limited by the diffusion of oxygen and nutrients  
into the organoids
Ability to capture sub-clonal populations in vitro Lacks secondary tissue that can be important for the interplay of  
cell–cell and cell–ECM cross talk
Can generate tissue from pluripotent cells Can display significant variability between preparations
Can be maintained for more than 1 year in long-term culture
Serial examination allows developmental study of tissue
Organ-on-a-chip Multifluidic chambers allow for the possibility of tissue/organ 
interconnection
Scaffolds used as ECM fails to mimic in vivo architecture and lack 
interrelationship and cross talk from multiple cell types
Utilizes smaller media volumes than static cultures in wells Simplified ECM can lead to matrix degradation or contraction and  
may suffer a high batch-to-batch variation
Fluid flow between channels allow prolonged culture periods 
than static cultures and facilitates cell growth environment
Complex channel designs make it difficult in cell seeding
Multi-organ system allows assessment of drug efficacy and 
toxicity predictions
Relies on a superficial model system to deliver fluids via microfluidic 
chambers
Allows high throughput sample processing and more realistic 
sample size
Variation in tools/scaffold/fluid quantity can affect outcome
Transparent nature of the fabrication materials makes imaging 
simpler
Fabrication process can prove technically challenging, leading  
to induction of bubbles and flow perturbations that can destroy  
cell cultures
Cell media may influence cell phenotype
Prolonged cultures reduce tissue viability
HOCs Provide cell–cell and cell–ECM interactions in a natural 
environment preserving endogenous molecules and growth 
factors
Human samples may be difficult to obtain; limitation in sample  
numbers may affect experimental design
Preserve the naturally complex stromal architecture, vascular 
networks, and parenchymal anatomy facilitating better response 
to external signals
Tissue viability reduced by prolonged cultures
Gene/protein expression profiling/imaging can be carried out  
on cultures using established tissue assays
Large samples may restrict delivery of oxygen and nutrients and 
penetration of exogenous stimuli
Variability in patient-to-patient responses to exogenous stimuli 
can be assessed
Real-time monitoring may be limited by the depth of the thickness  
of the tissue
TABLe 2 | Continued
OUTSTANDiNG QUeSTiONS
In this review, we have summarized how HOCs offer several sig-
nificant advantages as compared to conventional and newer 3D 
cultures for studies of patho-physiologic mechanisms that better 
reflect the in vivo situation. However, HOCs also have some limi-
tations. Chief among these is tissue acquisition, which results in 
limited sample size, variability, and heterogeneity. Heterogeneity 
and variability are problems faced in many human investiga-
tion and genetic analyses may help in stratification and lead to 
classifications into subtypes. In other words, this may be turned 
into an advantage if sufficient numbers of samples are available. 
Acquisition will remain a problem but can be partly addressed by 
an organized and efficient approach to ethical sample collection. 
Second major challenge is the limited viability of most organ 
culture systems. In our hands, deterioration in tissue architecture 
occurs after 18 h incubation. In general, more extended periods 
of survival will be needed to allow genetic techniques, such as 
RNAi-mediated gene knockdown or vector-mediated over-
expression to be carried out successfully. Protein transfection 
using cell-permeating tags on wild-type, constitutively active, or 
dominant-negative proteins may be used as alternatives. Other 
problems include uneven penetration or cellular uptake of vectors. 
Experience with siRNA in organ cultures has shown some success 
(46–48, 66). A third current limitation of HOCs that needs to be 
addressed is the lack of perfusion leading to metabolic perturba-
tions in the microenvironment. Perfusion itself may influence 
the system by providing shear stress and pulsations, physical 
signals especially important for vascular studies. Attempts have 
been made to address this issue (67), but further advances will 
be needed to develop a physiological flow system that allows for 
controlled hemodynamics in HOCs.
CONCLUSiON
In contrast to other experimental cultures commonly employed for 
basic research or preclinical drug testing in the human system, HOCs 
offer the advantage of studying tissue cells remaining within their 
at least partially intact microenvironment. Increasing data demon-
strate that cell lines, when kept in culture too long, exhibit reduced or 
altered key functions and often no longer represent reliable models 
of their original source material. HOCs preserve the integrity of 
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cells and matrices in an organ-specific structure and are more likely 
to be clinically relevant. The response of a whole integrated tissue 
to a simple ubiquitous signal will reflect not just the specificity of 
the signal or the receptor affinity, but also the microenvironment of 
juxtaposed cell types and ECM. Structural integrity is a major reason 
for adopting organ culture as an in  vitro method instead of cell 
culture. HOCs can model a wide range of applications that permit 
many functional and mechanistic studies and provide a simple but 
informative model in which to study the effects of pharmacological 
agents, cytokines, and various other mediators in humans.
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